XanGo® Juice’s Effect on CRP Levels


A double-blind placebo-controlled human clinical to evaluate the ability of XanGo Juice to reduce CRP levels in overweight persons.*

CRP stands for C - reactive protein, which is one of the indicators of cardiovascular health.

Researchers

Jay Udani, MD, CPI is the founder, CEO and Medical Director of Medicus Research. He is a board-certified Internist who served as Chief Resident at Cedars-Sinai Medical Center before completing two fellowships in Health-Services Research and Integrative Medicine at Cedars-Sinai/UCLA. He was one of the first physicians to become a Certified Principal Investigator (CPI) through the APPI/ACRP and as a Key Opinion Leader in the field of Integrative Medicine he has designed and performed over 60 clinical trials, and published over 40 articles and textbook chapters. He is the recipient of many prestigious awards including the 2008 Natural Products Association Clinician of the Year, the AMA National Achievement Award, the Harvard Medical School Pinkney Fellowship in Orthopaedic Research, and was voted Best Physician Specialist and Best Medical Speaker in Los Angeles by the Daily News.

Methods

The study was an 8-week randomized, double-blind, placebo-controlled study with a 2-week washout period for subjects who were currently taking anti-inflammatory or antioxidant products.

The purpose of this study was to evaluate the efficacy of multiple dosages of XanGo Juice compared with placebo in the improvement of CRP and antioxidant levels in obese patients with a confirmed history of inflammation.

Results

XanGo Juice was shown to reduce CRP levels and to improve weight and body fat in an overweight population. These results suggest that XanGo Juice may help maintain cardiovascular health.*

XanGo Juice demonstrated an ability to reduce CRP levels at all 3 dosages while the placebo group actually experienced a small increase in CRP levels. CRP decreased in all 3 dosages vs. placebo over the 8 week study with the 9 oz. XanGo Juice group being statistically significant when compared to placebo.

C-Reactive Protein


The XanGo Juice product was shown to be safe at all dosages tested. There were no adverse events (clinical, laboratory, or vital sign) attributed to the product during the course of the study.

To access the full length study, please visit Nutritionj.com (Nutrition Journal 2009, 8:48)

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.